Francois Fournier has left Fort Worth-based Galderma Laboratories LP, where he has been president since 2009. Galderma officials issued a statement today saying Fournier decided to leave his position as president.
The company most recently announced the FDA approval of Mirvaso for the topical treatment of the facial erythema (redness) of rosacea. “I am proud to have completed the successful launch of Mirvaso, a game-changer in the treatment of patients suffering from rosacea,” Fournier said in a a statement. “However, after an amazing 13 years with Galderma, I have decided it is time to pursue other professional opportunities and move on to the next phase of my career. This is not a decision that I have taken lightly and with the launch of Mirvaso and many interesting and exciting products to come, I am as confident as ever in the future of Galderma.”
With more than $2 billion in worldwide sales, the Fort Worth-based company was formed in 1981 as the North American operation of Swiss firm Galderma Pharma.- Carolyn Poirot